Twelve outstanding young scientists named as EMBO Young Investigators

07-Nov-2008 - Germany

The European molecular biology Organization (EMBO) announced the selection of 12 of Europe’s most talented young researchers as 2008 beneficiaries of the EMBO Young Investigator Programme. The programme annually identifies the brightest and most promising European young researchers at a critical stage of their scientific careers. Young group leaders receive a range of benefits designed to smooth the transition during the start up of their first independent research laboratories and as they develop reputations in the scientific community. The programme received 116 applications this year and successful recipients have established research groups in France, Germany, the United Kingdom, Spain and Switzerland.

“EMBO Young Investigators gain financial, academic and practical support to advance their careers,” explains Gerlind Wallon, EMBO Deputy Director and manager of the Young Investigator Programme. “The programme helps to endorse and promote these young scientists as active and recognised contributors to European research.”

Over the course of three years, EMBO Young Investigators will enjoy benefits not readily available to early-career scientists. Lab management and non-scientific skills training as well as PhD courses offer the young group leaders and their students the chance to develop professional skills. Networking events introduce them to recognised leaders in science like EMBO Members and other experts in their respective fields.

The 12 young group leaders honoured this year participate in the EMBO Young Investigator network - a group of more than 200 scientists. “The increasing number of participants each year makes the benefits of networking more tangible and concrete,” adds Gerlind Wallon.

EMBO Young Investigators receive 15,000 euro per year directly from the member state where their laboratories are located. Additional support is provided by EMBO for networking activities and small research projects in their laboratories.

2008 EMBO Young Investigators:

Óscar Fernández-Capetillo, Spain

Jesús Gil, United Kingdom

Monica Gotta, Switzerland

Giles Hardingham, United Kingdom

Juan Martín-Serrano, United Kingdom

Eric Miska, United Kingdom

Antonin Morillon, France

Antoine Peters, Switzerland

Erik Sahai, United Kingdom

Almut Schulze, United Kingdom

Mikael Simons, Germany

Eric So, United Kingdom

Other news from the department people

These products might interest you

Systec H-Series

Systec H-Series by Systec

Safe, reproducible and validatable sterilization of liquids, solids and waste

Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

laboratory autoclaves
Whatman™ folded filter papers

Whatman™ folded filter papers by Cytiva

Whatman folded filter papers

Convenient folded formats speed up your sample preparation

filter papers
Loading...

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Nobilon advances first vaccine into human trials - Intranasal influenza vaccine begins Phase I clinical development

Raptor Pharmaceuticals and TorreyPines Therapeutics Receive Stockholder Approvals to Merge - Merger to Create NASDAQ-Listed Biopharmaceutical Company named Raptor Pharmaceutical Corp.

Nobel Prize for Physiology or Medicine 2020 Announced - Nobel Prize awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus

Nobel Prize for Physiology or Medicine 2020 Announced - Nobel Prize awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus

PharmAthene and SIGA Technologies sign definitive merger agreement

PerkinElmer announces third quarter results - GAAP Revenue of $548 million versus $563 million in the comparable prior period

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria - Spin-out from the Universities of Glasgow and Oxford

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria - Spin-out from the Universities of Glasgow and Oxford

Doped by food - Dopamine release regulates our eating behaviour

Doped by food - Dopamine release regulates our eating behaviour

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant - Investment of more than € 140 million creates approximately 55 new jobs

Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant - Investment of more than € 140 million creates approximately 55 new jobs

Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy - Orikine Bio’s technology platform is on the cusp of revolutionizing the future of immunotherapy

Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy - Orikine Bio’s technology platform is on the cusp of revolutionizing the future of immunotherapy

Surface hygiene test wins the Chemical Industry Innovation Award